Terapie SARS-Cov-2 | Plasma da pazienti guariti

In rosso le review, in verde gli RCT.

• The Lancet, 14 maggio 2021 | “Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial”
• The Lancet, 14 maggio 2021, editoriale | “Convalescent plasma in patients hospitalised with COVID-19”
• New England Journal of Medicine, 18 marzo 2021 | “Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19”
• JAMA, 26 febbraio 2021 | “Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19A Systematic Review and Meta-analysis”
• New England Journal of Medicine, 18 febbraio 2021 | “Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults”
• New England Journal of Medicine, editoriale 18 febbraio 2021 | “(A Little) Clarity on Convalescent Plasma for Covid-19”
• New England Journal of Medicine, 18 febbraio 2021 | “A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia”
• New England Journal of Medicine, 13 gennaio 2021 | “Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19”
• Editoriale | “(A Little) Clarity on Convalescent Plasma for Covid-19”
• New England Journal of Medicine , 06 gennaio 2021 | “Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults”
• New England Journal of Medicine , 24 novembre 2020 | “A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia”
• Annals of Internal Medicine, 25 settembre 2020 | “Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel”
• Associazione Alessandro Liberati – Network Italiano Cochrane, 3 giugno 2020:                              Link: Plasma iperimmune in pazienti con COVID-19 grave: i risultati del primo RCT
• JAMA, 3 giugno 2020:                                                                                                                                        Link: Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19A Randomized Clinical Trial
• JAMA, Editoriale, 3 giugno 2020:                                                                                                                    Link: A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals
• Scienza in rete, 11 maggio 2020:
• Link: Plasmaterapia per Covid-19. Perché sì, perché no
• Nature Biotechnology, 1 maggio 2020:
  Link: Convalescent serum lines up as first-choice treatment for coronavirus
• The Journal of clinical investigation, 7 aprile 2020
  Link: Deployment of convalescent plasma for the prevention and treatment of COVID-19
• JAMA , 27 marzo 2020
  Link: Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma